Schrodinger(SDGR) - 2022 Q4 - Earnings Call Presentation

of 2015, 07 Second Quarter 2022 Supplemental Slides Transforming Discovery of Therapeutics and Materials February 28, 2023 Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advantag ...